Capital for Early Stage Innovation
Representatives from various investment firms explain the medical innovation funding landscape, and advise early stage innovators with creative ways to navigate these complexities.
Representatives from various investment firms explain the medical innovation funding landscape, and advise early stage innovators with creative ways to navigate these complexities.
Aron Cramer explains how bridging the gap between profit and nonprofit businesses would bring about social change and innovation.
Thomas Barry, founder of the Zephyr Management investment firm, discusses widespread opportunities for private equity investment in Africa.
Thomas Gibian, Chairman of Emerging Capital Partners, discusses the success of his organization in investing in companies across the African continent through seven funds.
Technologies that reduce costs and improve care for the underserved are often the most difficult to scale up. But a handful of strategies could turn things around.
Understanding these six important differences will both facilitate better conversations and help channel funds appropriately.
How to move from net zero to net impact.
There’s only one bottom line. It ought to be impact.
To get an idea of where impact investment might be headed over the next decade, the authors examine where the field has been in three areas that play an outsized role in its goals and practices.
It’s time for funders to get real about what social entrepreneurs need to succeed.